SCHEMBL13634657

SCHEMBL13634657

CCCNC(=O)c1cc(CN2CCO[C@@H](C)C2)ccc1NC(=O)c1csc(N2CC[C@H](OC)C2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.41
GRM2 Q14416 5/20 0.35
KCNH2 Q12809 1/20 0.35
GLS O94925 1/20 0.35
SCD O00767 2/20 0.35
SCD5 Q86SK9 2/20 0.35
HCAR1 Q9BXC0 1/20 0.34
PARP1 P09874 1/20 0.34
TNK1 Q13470 1/20 0.34
MCHR1 Q99705 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13634656 1.00 DRD4 (0.41) DRD4GRM2KCNH2GLSSCD
SCHEMBL2770243 0.95 KMT2A (0.38) DRD4GRM2KCNH2SCDSCD5
SCHEMBL13639001 0.95 KMT2A (0.38) DRD4GRM2KCNH2SCDSCD5
SCHEMBL13162737 0.94 GRM2 (0.36) DRD4GRM2KCNH2SCDSCD5
SCHEMBL13634725 0.93 DRD4 (0.46) DRD4GRM2KCNH2GLSSCD
SCHEMBL13634887 0.92 GLS (0.36) DRD4GLSSCDSCD5PARP1
SCHEMBL13634884 0.92 S1PR1 (0.40) DRD4MEN1ALDH1A1CYP1A2CYP3A4
Fumaric Acid SCHEMBL2771640 0.91 CCKAR (0.36) DRD4GRM2KCNH2SCDSCD5
Fumaric Acid SCHEMBL2771644 0.91 CCKAR (0.36) DRD4GRM2KCNH2SCDSCD5
SCHEMBL13164112 0.91 GRM2 (0.37) GRM2KCNH2SCDSCD5HCAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed